This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to IBD and Malignancies and to harmonise diagnostics and treatment in order to improve patient outcomes.

This course will follow the following cases on:

1. Colorectal cancer in IBD
   
2. Lymphoma risk following immunosuppressive therapy with thiopurines in IBD patients - cancer and IBD
   
3. Skin cancer in IBD
4. Chemotherapy in chronically active ulcerative colitis

Upon completion of this activity learners will have gained knowledge on:

• IBD and Solid Tumours
  
• IBD and Haematological Malignancies
  
• IBD and Skin Malignancies
• Management of IBD patients with a past history of malignancy

This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). The intended result of this activity is increased competence, knowledge, performance and improved patient outcomes.

Upon completion of this activity learners will:

• Have insights into the position of surgery versus medical therapy in patients with moderate-to-severe as well as acute severe IV steroid refractory colitis (UC)
• Be able to select the most optimal surgical modalities
• Gain knowledge on the appropriate follow-up of patients with an ileal pouch-anal anastomosis (IPAA)